Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral ...

Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...

This merged Peninsula biotech will have about $700 million to push three clinical trials — and potentially another drug — ...

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...

Former New Hampshire Gov. Chris Sununu (R) said Sunday that the Trump administration has “about six weeks” when it comes to a ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

The company improved its EBITDA margin by 500 basis points year-on-year in FY25, while its net debt-to-EBITDA ratio declined ...

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the ...